Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2007-9-11
pubmed:abstractText
Studies undertaken in academic settings have shown that bupropion hydrochloride can double the odds of smoking cessation compared with placebo. To assess whether these results are applicable in primary care, we launched a double-blind, placebo-controlled, randomized trial to be conducted by general practitioners.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0003-9926
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1791-7
pubmed:meshHeading
pubmed-meshheading:17846399-Adult, pubmed-meshheading:17846399-Antidepressive Agents, Second-Generation, pubmed-meshheading:17846399-Bupropion, pubmed-meshheading:17846399-Delayed-Action Preparations, pubmed-meshheading:17846399-Double-Blind Method, pubmed-meshheading:17846399-Female, pubmed-meshheading:17846399-Follow-Up Studies, pubmed-meshheading:17846399-Humans, pubmed-meshheading:17846399-Italy, pubmed-meshheading:17846399-Male, pubmed-meshheading:17846399-Middle Aged, pubmed-meshheading:17846399-Patient Compliance, pubmed-meshheading:17846399-Prevalence, pubmed-meshheading:17846399-Primary Health Care, pubmed-meshheading:17846399-Questionnaires, pubmed-meshheading:17846399-Retrospective Studies, pubmed-meshheading:17846399-Smoking, pubmed-meshheading:17846399-Smoking Cessation, pubmed-meshheading:17846399-Treatment Outcome, pubmed-meshheading:17846399-Weight Gain
pubmed:year
2007
pubmed:articleTitle
A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
pubmed:affiliation
Department of Oncology, Mario Negri Institute, Eritrea 62, Milan 20157, Italy. fossati@marionegri.it
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study